von innomma » Di Mär 19, 2024 3:58 am
hydroxychloroquine 400 mg potential as a therapeutic option in autoimmune hepatitis (AIH) is under investigation, particularly in cases resistant to conventional treatments like corticosteroids and immunosuppressants. Preliminary studies suggest that it may help achieve disease remission and reduce the need for high-dose immunosuppression, although more research is needed to confirm its efficacy.
[url=https://plaqcmd.com]hydroxychloroquine 400 mg[/url] potential as a therapeutic option in autoimmune hepatitis (AIH) is under investigation, particularly in cases resistant to conventional treatments like corticosteroids and immunosuppressants. Preliminary studies suggest that it may help achieve disease remission and reduce the need for high-dose immunosuppression, although more research is needed to confirm its efficacy.